Novavax Inc.

NASDAQ: NVAX · Real-Time Price · USD
9.58
0.15 (1.59%)
At close: Aug 15, 2025, 3:59 PM
9.63
0.52%
After-hours: Aug 15, 2025, 07:58 PM EDT

Novavax Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
239.24M 666.65M 88.31M 84.51M 415.48M 93.86M 291.34M 22.06M 424.43M 80.95M 287.83M 734.58M 185.93M 703.97M 222.2M 178.84M 298.02M 447.23M
Cost of Revenue
14.22M 14.12M 36.67M 60.62M 36.04M 48.81M 148.88M 98.93M 55.78M 34.09M 181.76M 434.59M 271.08M 15.2M 3.67M n/a n/a n/a
Gross Profit
225.01M 652.54M 51.64M 23.89M 379.44M 45.05M 142.47M -76.86M 368.65M 46.87M 106.06M 299.98M -85.15M 688.77M 218.53M 178.84M 298.02M 447.23M
Operating Income
105.67M 515.51M -131.08M -134.02M 161M -138.73M -183.57M -125.63M 55.46M -312.77M -243.88M -127.19M -482.96M 209.29M -824.97M -307.14M -345.83M -208.63M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 2.86M 3.12M 4.32M 4.6M 4.17M n/a n/a n/a n/a n/a n/a
Pretax Income
107.45M 519.85M -73.58M -122.33M 164.59M -145.29M -176.7M -131.47M 57.87M -292.72M -184.51M -166.14M -509.07M 206.07M -829.67M -316.39M -348.77M -219.7M
Net Income
106.51M 518.65M -81.03M -121.3M 162.38M -147.55M -178.39M -130.78M 58.01M -293.9M -182.25M -168.61M -510.49M 203.41M -846.28M -322.43M -352.32M -222.72M
Selling & General & Admin
40.61M 48.09M 78.34M 70.75M 101.3M 82.3M 155.24M 107.46M 93.72M 112.53M 161.66M 122.88M 108.16M 95.99M 84.21M 77.79M 73.16M 63.19M
Research & Development
77.63M 88.94M 104.28M 87.16M 106.95M 92.68M 164.7M 106.23M 219.47M 247.1M 257.85M 304.3M 289.65M 383.48M 962.96M 408.19M 570.68M 592.67M
Other Expenses
1.1M n/a n/a n/a n/a -8.8M -6.1M -2.98M n/a -87.38M -69.57M n/a n/a 1.65M 131K -4.39M 2.66M n/a
Operating Expenses
119.34M 137.03M 187.22M 157.91M 208.24M 183.78M 326.03M 48.77M 313.19M 272.25M 349.94M 427.17M 397.81M 479.48M 1.05B 485.99M 643.85M 655.86M
Interest Expense
5.52M -5.72M 7.58M 4.24M 4.14M 4.11M 4.12M 2.86M 3.12M 4.32M 4.6M 4.17M 6.23M 4.52M 5.14M 5.18M 5.97M 4.84M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -165.37M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
133.57M 151.14M 219.39M 218.53M 253.37M 232.59M 474.91M 147.7M 368.97M 306.34M 531.71M 861.77M 668.88M 494.68M 1.05B 485.99M 643.85M 655.86M
Income Tax Expense
946K 1.2M 7.45M -1.03M 2.21M 2.26M 1.69M -697K -143K 1.18M -2.26M 2.47M 1.42M 2.66M 16.61M 6.04M 3.55M 3.02M
Shares Outstanding (Basic)
162.02M 161.05M 160.24M 160.05M 148.38M 139.92M 123.68M 103.43M 89.36M 86.16M 79.82M 78.27M 78.14M 79.38M 75.67M 74.75M 74.12M 73.02M
Shares Outstanding (Diluted)
177.22M 177.63M 160.24M 160.05M 165.85M 139.92M 123.68M 103.43M 104.06M 86.16M 79.82M 78.27M 78.14M 80.71M 75.67M 74.75M 74.12M 73.03M
EPS (Basic)
0.66 3.22 -0.51 -0.76 1.11 -1.05 -1.44 -1.26 0.65 -3.41 -2.28 -2.15 -6.53 2.56 -11.18 -4.31 -4.75 -3.05
EPS (Diluted)
0.60 2.93 -0.51 -0.76 0.99 -1.05 -1.44 -1.26 0.58 -3.41 -2.28 -2.15 -6.53 2.52 -11.18 -4.31 -4.75 -3.05
EBITDA
120.53M 533.91M -53.48M -105.4M 179.86M -129.03M -161.79M -117.29M 71.06M -279.36M -172.09M -153.63M -496.11M 217.71M -820.87M -306.95M -340.39M -212.55M
EBIT
112.97M 525.57M -66M -118.1M 168.73M -141.18M -172.58M -128.61M 60.99M -288.41M -179.91M -161.97M -502.83M 210.95M -824.54M -311.21M -342.8M -215.22M
Depreciation & Amortization
7.56M 8.34M 12.52M 12.7M 11.13M 12.15M 10.79M 11.32M 10.07M 9.04M 7.82M 8.35M 6.72M 6.76M 3.67M 4.26M 2.41M 2.32M